TSE:CUR

45525 (CUR.TO) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average Volume130,253 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive CUR News and Ratings via Email

Sign-up to receive the latest news and ratings for 45525 (CUR.TO) and its competitors with MarketBeat's FREE daily newsletter.

About 45525 (CUR.TO)

9342-8530 Quebec Inc, formerly Diagnocure Inc, is a Canada-based biotechnology company. The Company specializes in the development and commercialization of products relating to the diagnosis of cancer. It intends to focus its activities on business development efforts by out-licensing, selling or partnering with third parties with regards to its Previstage GCC and its new multimarker prostate cancer test (PCP). The Company's colorectal cancer staging test, Previstage GCC, uses the Guanylyl Cyclase C (GCC or GUCY2C) marker to stratify the risk of colon cancer recurrence by determining the stage of the disease. Previstage GCC Colorectal Cancer Staging test is a molecular test for the staging of colorectal cancer patients. The PROGENSA PCA3 assay is a molecular urine test that can be used as a predictor of biopsy outcome in men with a serum prostate specific antigen (PSA) level over 2.5 nanograms per milliliter (ng/ml).

Herpes Simplex Virus Testing Kits Market Research Study including Growth Factors, Types and Application by regions from 2020 to 2026
September 24, 2020 | marketwatch.com

BioMark Appoints Dr. Jean-Francois Haince as Strategic Advisor to Guide Its Expansion into Quebec
September 16, 2020 | finance.yahoo.com

Herpes Simplex Virus Testing Market Global Research and Analysis 2020 to 2026
August 14, 2020 | marketwatch.com

Biomarker Technologies Market Research, Industry Outlook, Current Trends and Forecast by 2027
August 12, 2020 | marketwatch.com

Biomarker Technologies Market Growth By Manufacturers, Type And Application, Forecast To 2026
August 4, 2020 | marketwatch.com

Makers of rapid test kits flounder as unclear policy constricts market size
July 26, 2020 | www.msn.com

Global Chlamydia Diagnostic Testing Market 2020 Share, Top Key Players, Price, Revenue and Growth Rate Forecast 2025
July 6, 2020 | www.marketwatch.com

Chlamydia Infection Test Market 2020 Share, Growth Factor, Top Key Players, Market Size, Revenue, Price and Gross Margin Forecast to 2025
July 6, 2020 | www.marketwatch.com

Diagnocure Stock
June 28, 2020 | markets.businessinsider.com

COVID-19 Impact on Biomarker Technologies Market
June 10, 2020 | www.marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE
Industry Biotechnology
Sub-IndustryN/A
SectorHealth Technology
Current SymbolTSE:CUR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.neuralstem.com
Phone+1-418-5276100
Employees6
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.85 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 45525 (CUR.TO).

4.3 Community Rank

Outperform Votes
45525 (CUR.TO) has received 42 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
45525 (CUR.TO) has received 23 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
45525 (CUR.TO) has received 64.62% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about 45525 (CUR.TO) and other stocks. Vote “Outperform” if you believe CUR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CUR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
45525 (CUR.TO) does not currently pay a dividend.
Dividend Growth
45525 (CUR.TO) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 45525 (CUR.TO) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

45525 (CUR.TO) (TSE:CUR) Frequently Asked Questions

What stocks does MarketBeat like better than 45525 (CUR.TO)?

Wall Street analysts have given 45525 (CUR.TO) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 45525 (CUR.TO) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are some of 45525 (CUR.TO)'s key competitors?

Some companies that are related to 45525 (CUR.TO) include (TNGN) (TNGN), 3SBio (TRSBF), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR), Annovis Bio (ANVS) and Arno Therapeutics (ARNI).
View all of CUR's competitors.

What other stocks do shareholders of 45525 (CUR.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 45525 (CUR.TO) investors own include Soleno Therapeutics (SLNO), Adverum Biotechnologies (ADVM), Adient (ADNT), Adaptimmune Therapeutics (ADAP), AcelRx Pharmaceuticals (ACRX), Aclaris Therapeutics (ACRS), ACM Research (ACMR), Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS).

What is 45525 (CUR.TO)'s stock symbol?

45525 (CUR.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CUR."

How do I buy shares of 45525 (CUR.TO)?

Shares of CUR and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How many employees does 45525 (CUR.TO) have?

45525 (CUR.TO) employs 6 workers across the globe.

What is 45525 (CUR.TO)'s official website?

The official website for 45525 (CUR.TO) is www.neuralstem.com.

Where are 45525 (CUR.TO)'s headquarters?

45525 (CUR.TO) is headquartered at 250-4535 Wilfrid-Hamel Blvd, QUEBEC, QC G1P 2J7, Canada.

How can I contact 45525 (CUR.TO)?

45525 (CUR.TO)'s mailing address is 250-4535 Wilfrid-Hamel Blvd, QUEBEC, QC G1P 2J7, Canada. The biotechnology company can be reached via phone at +1-418-5276100.

This page was last updated on 9/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.